Related Experiment Video
Updated: Jul 5, 2026

08:35
Production and Titering of Recombinant Adeno-associated Viral Vectors
Published on: November 27, 2011
AAV vectors for RNA-based modulation of gene expression
1Inserm U781, Hôpital Necker-Enfants Malades & Université Paris Descartes, Paris, France. olivier.danos@necker.fr
Gene Therapy
|April 18, 2008
Summary
Gene expression regulation involves intricate molecular machines. Adeno-associated virus technology enables non-coding RNA expression for functional genomics and therapeutic strategies.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Gene expression is regulated post-transcriptionally by molecular machines controlling RNA processing, transport, translation, and degradation.
- These processes rely on nucleoprotein complexes recognizing specific RNA sequence motifs.
- Targeting these motifs with complementary RNA sequences can alter cell phenotype or correct mutations.
Purpose of the Study:
- To review the application of adeno-associated virus (AAV) technology for expressing non-coding RNAs.
- To explore the use of AAV-mediated non-coding RNA expression in functional genomic studies.
- To discuss the potential of AAV technology in developing novel therapeutic strategies.
Main Methods:
- Utilizing adeno-associated virus vectors for efficient gene delivery.
- Expressing non-coding RNAs to modulate gene expression at the post-transcriptional level.
- Employing Watson-Crick base pairing to mask target RNA sequences.
Main Results:
- Adeno-associated virus technology is effective for expressing non-coding RNAs in various tissues, including the brain, muscle, and liver.
- This approach allows for precise manipulation of cellular phenotypes.
- It offers a method to compensate for the detrimental effects of genetic mutations.
Conclusions:
- Adeno-associated virus technology is a versatile tool for functional genomics and therapeutic development.
- Non-coding RNA expression via AAV provides a powerful strategy for gene regulation.
- This technology holds significant promise for treating genetic disorders.
More Related Videos
Related Concept Videos
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Editing
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...

